-
Biopharmaceutical |Cardiovascular Diseases |L-Octahydroindole-2-carboxylicacidbenzylester 4-methylbenzenesulfonate |CAS: 94062-52-9 |C16H21NO2.C7H8O3S
Profesjonele manufacturing en oanbod biopharmaceutical |Raw Materials |Pharmaceutical Intermediates Reagents |Cardiovascular Diseases |Hege bloeddruk |L-Octahydroindole-2-carboxylicacidbenzylester 4-methylbenzenesulfonate |CAS: 94062-52-9 |C16H21NO2.C7H8O3S
-
Biopharmaceutical |Cardiovascular Diseases |2-Chloor-L-fenylalanine |CAS: 103616-89-3
Profesjonele manufacturing en oanbod biopharmaceutical |Raw Materials |Pharmaceutical Intermediates Reagents |Cardiovascular Diseases |Hege bloeddruk |2-Chloor-L-fenylalanine |CAS: 103616-89-3 |C9H10ClNO2
-
Raw Materials |Pharmaceutical Intermediates |Cardiovascular |Sykten |L-Norvaline ethyl ester hydrochloride |CAS: 40918-51-2 |C7H16ClNO2
Profesjonele manufacturing en oanbod biopharmaceutical |Raw Materials |Pharmaceutical Intermediates Reagents |Cardiovascular Diseases |Hege bloeddruk |L-Norvaline ethyl ester hydrochloride |CAS: 40918-51-2 |C7H16ClNO2
-
![Raw Materials |Pharmaceutical Intermediates |Cardiovascular |Sykten |N-[(S)-1-Carbethoxy-1-butyl]-(S)-alanine |CAS: 82834-12-6 |C10H19NO4](https://www.yisunbio.com/uploads/82834-12-6.jpg)
Raw Materials |Pharmaceutical Intermediates |Cardiovascular |Sykten |N-[(S)-1-Carbethoxy-1-butyl]-(S)-alanine |CAS: 82834-12-6 |C10H19NO4
Profesjonele manufacturing en oanbod biopharmaceutical |Raw Materials |Pharmaceutical Intermediates Reagents |Cardiovascular Diseases |Hege bloeddruk |N-[(S)-1-Carbethoxy-1-butyl]-(S)-alanine |CAS: 82834-12-6 |C10H19NO4
-
Raw Materials |Pharmaceutical Intermediates |Cardiovascular |Sykten |(2S,3aS,7aS)-Octahydro-1H-indole-2-carboxylic acid |CAS: 80875-98-5
Profesjonele manufacturing en oanbod biopharmaceutical |Raw Materials |Pharmaceutical Intermediates Reagents |Cardiovascular Diseases |Hege bloeddruk |(2S,3aS,7aS)-Octahydro-1H-indole-2-carboxylic acid |CAS: 80875-98-5 |C9H15NO2
-
Pharmaceutical Intermediates |Dabigatran Intermediates |N-(4-CYANO-PHENYL)-GLYSINE |CAS No.42288-26-6
Profesjonele manufacturing en oanbod biopharmaceutical |Pharmaceutical Intermediates Reagents |Grûnstoffen |Anticoagulant API |Dabigatran Intermediates |N-(4-CYANO-PHENYL)-GLYSINE |CAS: 42288-26-6 |C9H8N2O2
-
Raw Materials |Pharmaceutical Intermediates |Cardiovascular |Sykten |(S)-(-)-indoline-2-carboxylic acid |CAS No.79815-20-6
Profesjonele manufacturing en oanbod biopharmaceutical |Raw Materials |Pharmaceutical Intermediates Reagents |Cardiovascular Diseases |Hege bloeddruk |(S)-(-)-indoline-2-carboxylic acid |CAS: 79815-20-6 |C9H9NO2
-
Biopharmaceutical |Cardiovascular Diseases |2-Chloor-L-fenylalanine |CAS No.185030-83-5
Profesjonele manufacturing en oanbod biopharmaceutical |Raw Materials |Pharmaceutical Intermediates Reagents |Cardiovascular Diseases |Hege bloeddruk |2-CHLORO-L-PHENYLALANINE |CAS:185030-83-5 |C9H10ClNO2
-
Benazepril hydrochloride 86541-74-4
Profesjonele manufacturing en oanbod biopharmaceutical |Raw Materials |Pharmaceutical Intermediates Reagents |Cardiovascular Diseases |Hege bloeddruk |Benazepril hydrochloride |CAS:86541-74-4|C24H28N2O5.HCl
-
Valsartan 137862-53-4
Profesjonele manufacturing en oanbod biopharmaceutical |Chemical Reagents |Gemyske grûnstoffen |Yndustriële farmaseutyske tuskenlizzende |Cardiovascular |Hypertensie behanneling |Valsartan Intermediates |Valsartan |CAS:137862-53-4 |C24H29N5O3
-
L-Valine methylester hydrochloride 6306-52-1
Profesjonele manufacturing en oanbod biopharmaceutical |Chemical Reagents |Gemyske grûnstoffen |Yndustriële farmaseutyske tuskenlizzende |Cardiovascular |Valsartan Intermediates |L-Valine methylester hydrochloride |CAS: 6306-52-1 |C6H13NO2.HCl
-
![N-[(2'-cyano[1,1'-bifenyl]-4-yl)methyl]-L-valine methylester hydrochloride 482577-59-3](https://www.yisunbio.com/uploads/34.jpg)
N-[(2'-cyano[1,1'-bifenyl]-4-yl)methyl]-L-valine methylester hydrochloride 482577-59-3
Profesjonele manufacturing en oanbod biopharmaceutical |Chemical Reagents |Gemyske grûnstoffen |Yndustriële farmaseutyske tuskenlizzende |Cardiovascular |Hypertensie behanneling |Valsartan Intermediates |N-[(2'-Cyano[1,1'-bifenyl]-4-yl)methyl]-L-valinemethylesterhydrochloride |CAS: 482577-59-3 |C20H22N2O2.HCl